Journal article · 2026 · Open access
Efficacy and cost effectiveness of high volume injections with and without corticosteroid compared with sham for midportion Achilles tendinopathy (Inject trial): randomised controlled trial
BMJ, 395, e100807 · Published 28 October 2026 · DOI 10.1136/bmj-2026-100807
In brief
“Efficacy and cost effectiveness of high volume injections with and without corticosteroid compared with sham for midportion Achilles tendinopathy (Inject trial): randomised controlled trial” is a 2026 journal article by Peter Malliaras and 10 co-authors, published in BMJ. OpenAlex counts 1 citations as of 17 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access under a CC BY-NC licence: the full text is free to read at BMJ.
- Citations
- 1
- Most cited in
- 2026 (1)
- Field-weighted impact
- 4.77
- References
- 43
- Authors
- 11
Abstract
OBJECTIVE: To test the efficacy and cost effectiveness of high volume injections with and without corticosteroid versus sham injection for midportion Achilles tendinopathy. DESIGN: Single centred, participant and assessor masked, three arm randomised controlled trial (Inject trial). SETTING: Community. PARTICIPANTS: From 5 December 2019 and 24 July 2022, 192 adults (18 years or older) diagnosed with midportion Achilles tendinopathy were randomly assigned (1:1:1) to sham (n=64), high volume injection without corticosteroid (n=63), or high volume injection with corticosteroid (n=65). INTERVENTIONS: Participants were allocated to sham injection (2-3 mL 0.5% bupivacaine hydrochloride), high volume injection with corticosteroid (50 mL saline and 0.5% bupivacaine with 25 mg hydrocortisone in the first 10 mL), or high volume injection with no corticosteroid (same solution but without hydrocortisone). They received the same exercise programme, education, and activity modification advice. MAIN OUTCOME MEASURES: The primary clinical outcome was pain and disability using the validated VISA-A and the primary endpoint was at 52 weeks. The economic outcome was cost per quality-adjusted life-years from a societal perspective. RESULTS: VISA-A data were obtained from 181 (94%) of 192 participants at 12 months. No clear differences were noted between sham and high volume injection either with (-3.5 (98.33% confidence interval -12.0 to 5.0)) or without corticosteroid (4.0 (-4.2 to 12.3)), and between the two injections (-7.5 (-15.3 to 0.3)), at 12 months. The point estimate was closest to the target difference for the comparison between injections and favoured the arm without steroid. The only differences observed on VISA-A at intermediate time points were a benefit for high volume with corticosteroid versus sham at six weeks (9.2 (1.5 to 16.9)) but worse outcomes for high volume injection with corticosteroid versus high volume injection with no corticosteroid at 26 weeks (-8.6 (-16.4 to -0.7)). The health economic analysis found high volume injection with corticosteroid to be less costly than the sham with similar effectiveness based on quality-adjusted life-years (>0.90 probability of being cost effective at $AUD50 000 and $100 000 willingness-to-pay thresholds). No serious trial related adverse events were recorded. CONCLUSION: High volume injections with or without corticosteroids did not improve pain or disability compared with sham at 12 months. Although high volume injections with corticosteroid showed short term clinical benefit and potential reduction in healthcare costs over a year, they were associated with worse longer term clinical outcomes. The clinical data do not support routine use for high volume injections with corticosteroid for midportion Achilles tendinopathy. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12619001455156.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Malliaras, P., Connell, D., Boesen, A., Kearney, R. S., Menz, H. B., Morrissey, D., Munteanu, S. E., Silbernagel, K. G., Underwood, M. R., Forbes, A. B., & Haines, T. P. (2026). Efficacy and cost effectiveness of high volume injections with and without corticosteroid compared with sham for midportion Achilles tendinopathy (Inject trial): randomised controlled trial. BMJ, 395, e100807. https://doi.org/10.1136/bmj-2026-100807
MLA 9
Malliaras, Peter, et al. “Efficacy and cost effectiveness of high volume injections with and without corticosteroid compared with sham for midportion Achilles tendinopathy (Inject trial): randomised controlled trial.” BMJ, vol. 395, 2026, p. e100807. https://doi.org/10.1136/bmj-2026-100807.
Chicago
Malliaras, Peter, David Connell, Anders Boesen, Rebecca Samantha Kearney, Hylton B. Menz, Dylan Morrissey, Shannon E. Munteanu, et al. 2026. “Efficacy and cost effectiveness of high volume injections with and without corticosteroid compared with sham for midportion Achilles tendinopathy (Inject trial): randomised controlled trial.” BMJ 395: e100807. https://doi.org/10.1136/bmj-2026-100807.
Harvard
Malliaras, P. et al. (2026) ‘Efficacy and cost effectiveness of high volume injections with and without corticosteroid compared with sham for midportion Achilles tendinopathy (Inject trial): randomised controlled trial’, BMJ, 395, p. e100807. doi:10.1136/bmj-2026-100807.
IEEE
P. Malliaras et al., “Efficacy and cost effectiveness of high volume injections with and without corticosteroid compared with sham for midportion Achilles tendinopathy (Inject trial): randomised controlled trial,” BMJ, vol. 395, p. e100807, 2026, doi: 10.1136/bmj-2026-100807.
BibTeX
@article{malliaras2026efficacy,
title = {{Efficacy and cost effectiveness of high volume injections with and without corticosteroid compared with sham for midportion Achilles tendinopathy (Inject trial): randomised controlled trial}},
author = {Malliaras, Peter and Connell, David and Boesen, Anders and Kearney, Rebecca Samantha and Menz, Hylton B. and Morrissey, Dylan and Munteanu, Shannon E. and Silbernagel, Karin Grävare and Underwood, Martin R and Forbes, Andrew Benjamin and Haines, Terry P.},
journal = {BMJ},
year = {2026},
volume = {395},
pages = {e100807},
doi = {10.1136/bmj-2026-100807},
url = {https://doi.org/10.1136/bmj-2026-100807}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
- midportion Achilles tendinopathy
- corticosteroid injection
- cortisol
- sham injection
- bupivacaine
- VISA-A
- pain and disability
- cost per quality-adjusted life year
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Malliaras, P., Connell, D., Boesen, A., Kearney, R. S., Menz, H. B., Morrissey, D., Munteanu, S. E., Silbernagel, K. G., Underwood, M. R., Forbes, A. B., & Haines, T. P. (2026). Efficacy and cost effectiveness of high volume injections with and without corticosteroid compared with sham for midportion Achilles tendinopathy (Inject trial): randomised controlled trial. BMJ, 395, e100807. https://doi.org/10.1136/bmj-2026-100807
How many times has this paper been cited?
1 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at BMJ: sign in and open the PDF from this page.
Who wrote this paper?
Peter Malliaras, David Connell, Anders Boesen, Rebecca Samantha Kearney, Hylton B. Menz, Dylan Morrissey, Shannon E. Munteanu, Karin Grävare Silbernagel, Martin R Underwood, Andrew Benjamin Forbes, Terry P. Haines.
What is the DOI of this paper?
10.1136/bmj-2026-100807, permanently at https://doi.org/10.1136/bmj-2026-100807. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.